HOME › DRUGS › BENRALIZUMAB
ACTIVE SUBSTANCE / INN

BENRALIZUMAB

Brand name(s): Fasenra, FASENRA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761070
Asthma
ACTIVE SUBSTANCE
Benralizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
ASTRAZENECA AB, AstraZeneca AB
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
FASENRABLA761070ASTRAZENECA ABPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FasenraAstraZeneca ABAuthorised08/01/2018Asthma

FULL INTELLIGENCE ON BENRALIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →